ASTROTECH Corp Proceeds from Notes Payable
ASTROTECH Corp (ASTC) reported Proceeds from Notes Payable of $0 for the 12-month period ending 2021-06-30, per its 10-K filed 2021-09-21.
Discontinued › Cash Flow › Financing Activities
us-gaap:ProceedsFromNotesPayable · last filed 2021-09-21
- ASTROTECH Corp proceeds from notes payable for fiscal 2021 was $0.00, a 100.00% decline from fiscal 2020.
- ASTROTECH Corp proceeds from notes payable for fiscal 2020 was $542.00K.
- ASTROTECH Corp proceeds from notes payable for fiscal 2019 was $0.00.
| Period end | Proceeds from Notes Payable 12 month |
|---|---|
| 2021-06-30 | $0.00 10-K · filed 2021-09-21 |
| 2020-06-30 | $542.00K 10-K · filed 2021-09-21 |
| 2019-06-30 | $0.00 10-K · filed 2020-09-08 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Bionano Genomics, Inc. (BNGO) | United States | $0.020B | -0.42 |
| HARVARD BIOSCIENCE INC (HBIO) | United States | $0.037B | -2.70 |
| Precipio, Inc. (PRPO) | United States | $0.043B | -36.70 |
| Seer, Inc. (SEER) | United States | $0.104B | -1.34 |
| Nautilus Biotechnology, Inc. (NAUT) | United States | $0.129B | -4.16 |
| Quanterix Corp (QTRX) | United States | $0.150B | -1.65 |
| EyePoint, Inc. (EYPT) | United States | $0.314B | -3.96 |
| 908 Devices Inc. (MASS) | United States | $0.476B | -9.53 |
| PACIFIC BIOSCIENCES OF CALIFORNIA, INC. (PACB) | United States | $0.491B | -3.95 |
| Cytek Biosciences, Inc. (CTKB) | United States | $0.744B | -7.15 |